FPT-CORPORATION
25.3.2024 09:07:34 CET | Business Wire | Press release
Global IT corporation FPT and De Heus recently entered a strategic partnership to foster the agriculture giant's security operations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240320729005/en/
De Heus Vietnam COO Rick van der Linden (L) and FPT Software Europe CEO Tran Van Dung (R) at the signing ceremony attended by senior leaders of the Netherlands government during the economic mission to Vietnam (Photo: Business Wire)
The two firms will join forces to support De Heus’ Security Operations Center, focusing on the scope of Security Information and Event Management (SIEM). Leveraging FPT's prowess in technology and high-quality workforce, this movement will bolster De Heus’ capabilities in terms of system monitoring, security breach detection, and defense measures to effectively mitigate cyber risk and safeguard its information system and security data on a global scale.
The partnership marks a significant milestone for De Heus' digital transformation strategy amid rising cyberattack concerns in the manufacturing and agriculture industries. Both parties expect this to set a solid foundation for future collaborations in other areas like artificial intelligence, machine learning, big data, and more to further advance De Heus' and the agriculture industry's growth.
Tran Van Dung, Chief Executive Officer of FPT Software Europe, said: “While all businesses want to scale their digital transformation initiatives quickly, doing so securely is equally imperative in the face of cyber threats. Leveraging our extensive expertise and demonstrated success in deploying SIEM projects for multinational corporations globally, we stand ready to optimize De Heus' security operations.”
Rick van der Linden, Chief Operating Officer of De Heus Viet Nam, shared: “Through this partnership, FPT and De Heus are committing to leveraging our collective expertise and resources to develop robust security frameworks that will withstand the test of time. Together, we will explore innovative solutions and best practices to enhance cybersecurity measures and protect against emerging threats.”
The signing ceremony was attended by the Netherlands Minister of Infrastructure and Water Management, Mark Harbers; Minister of Agriculture, Nature, and Food Quality, Christianne van der Wal; Chair of the Confederation of Netherlands Industry and Employers, Ingrid Thijssen; and over 140 large enterprises from the Netherlands in pivotal fields of high-tech manufacturing, sustainable agriculture and food production, renewable energy, logistics, and climate adaptation and water.
Established its first office in 2008 in France, FPT has expanded its presence to 16 offices across 9 countries, serving over 70 leading businesses across Europe. Over the past decade, the tech firm has also been actively intensifying its local footprint and delivery capabilities through partnerships and acquisitions ventures, notably with the acquisition of RWE IT Slovakia, a subsidiary of European energy giant RWE in 2014, and the French IT Consulting Firm AOSIS in 2023.
About FPT Corporation
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of US$2.17 billion and 73,000 employees. For more information, please visit https://fpt.com.vn/en.
About De Heus
De Heus Vietnam, a member of Royal De Heus Group, has been proud to be Vietnam's leading animal feed supplier since 2008. De Heus provides farmers comprehensive nutritional solutions to help improve livestock productivity and product quality. With a team of experienced experts and a modern factory system, De Heus is committed to providing high-quality animal feed for all types of animals, from livestock, poultry, and aquaculture to pets. De Heus' reputable brands, such as De Heus, Windmill, Koudijs, Con Cò, and Anco, have become familiar to Vietnamese farmers. De Heus always accompanies Vietnamese farmers, aiming towards developing a sustainable and prosperous agriculture.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240320729005/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom